You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

HEPARIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Heparin, and when can generic versions of Heparin launch?

Heparin is a drug marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Aspen Global Inc, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Epic Pharma Llc, Fresenius Kabi Usa, Gland, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, Baxter Hlthcare, Mcgaw, B Braun, and Pharma Serve Ny. and is included in eighty-four NDAs.

The generic ingredient in HEPARIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Heparin

A generic version of HEPARIN was approved as heparin sodium by HOSPIRA on April 28^th, 1983.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for HEPARIN?
What are the global sales for HEPARIN?
What is Average Wholesale Price for HEPARIN?

Summary for HEPARIN

US Patents:	0
Applicants:	33
NDAs:	84
Drug Prices:	Drug price information for HEPARIN
DailyMed Link:	HEPARIN at DailyMed

Drug patent expirations by year for HEPARIN

Drug Prices for HEPARIN

US Patents and Regulatory Information for HEPARIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	017037-002	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Parke Davis	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	017346-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dr Reddys	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	017064-015	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.